Press Releases

Featured Press Releases

BIO Applauds Introduction of Bipartisan…

BIO President and CEO John F. Crowley today released the following statement after a bipartisan group of Senators, Sen. Bob Casey (D-PA), Sen. Markwayne Mullin (R-OK), Sen. Sherrod Brown (D-OH), and Sen. Susan Collins (R-ME), introduced the Creating…

Learn more

BIO International Convention Celebrates Another…

Biotechnology Innovation Organization (BIO) is proud to conclude the 2024 BIO International Convention in San Diego, held last week June 3-6, 2024. 1,400 exhibitors and more than 19,500 attendees from 70 countries came together for four full days of…

Learn more

BIO Recognizes Industry Leaders for…

WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette Kleiser, CEO of Dalan Animal Health, as the recipient…

Learn more

BIO Appoints a Physician-Scientist as New President and CEO

May 14, 2020

Immunologist Michelle McMurry-Heath is Selected for Her Global Leadership and Commitment to Innovation and Patients Former FDA Official Will Succeed Industry Leader Jim Greenwood on June 1 as Leader of World’s Largest Biotechnology…

Dr. Moncef Slaoui “Excellent Choice” to Lead Operation Warp Speed

May 13, 2020

Following the announcement that Dr. Moncef Slaoui will lead the Trump Administration's "Operation Warp Speed" initiative, BIO’s President and CEO, Jim Greenwood, issued the following statement: “Dr. Moncef Slaoui is an excellent choice…

New Medicine Pipeline Tracker Illustrates Unprecedented Effort to Eradicate COVID-19

May 12, 2020

The Biotechnology Innovation Organization (BIO) today unveiled a first-of-its-kind, interactive tracker of the new treatments and vaccines in the COVID-19 pipeline. This online resource illustrates the unprecedented campaign being undertaken by…

CMS Announcement an Important Step Forward for Patients, Transformative Therapies

May 11, 2020

Today, the Centers for Medicare and Medicaid Services announced that it is proposing to create a new Medicare-severity-diagnosis related group (MS-DRG) designed specifically for reimbursing providers administering CAR T-cell therapies to cancer…

BIO Supports State and Congressional Efforts to Reject Gratuitous Requests From Oil Industry

May 8, 2020

Washington, D.C. (May 8, 2020) – The Biotechnology Innovation Organization (BIO) today released the following statement in support of the Governors' Biofuels Coalition letter urging EPA to reject unjustifiable Renewable Fuel Standard (RFS)…

Administration’s Benefit Rule Threatens Access and Affordability of Prescription Medicines

May 7, 2020

BIO’s Tom DiLenge, President of Advocacy, Law & Public Policy Division issued the following statement today after the Trump administration adopted a “Notice of Benefit and Payment Parameters for 2021” that allows health plans to block drug…

New Online IP Marketplace Will Foster Collaboration in Race to Eradicate COVID-19

May 4, 2020

To help in the response to the coronavirus pandemic, the U.S. Patent and Trademark Office today launched a new online platform, called “Patents 4 Partnerships,” to share patent information for various technologies to facilitate greater collaboration…

BIO Helps Capital Area Food Bank Meet Demand for Food in Wake of COVID-19 Outbreak

April 15, 2020

The Biotechnology Innovation Organization (BIO) is donating $10,000 to the Capital Area Food Bank to help the organization meet the increased demand for healthy and fresh food in the Washington, D.C. community due to the coronavirus outbreak. “As…

2020 BIO International Convention Now Fully Digital

April 3, 2020

The Biotechnology Innovation Organization (BIO) announced today it will be moving the 2020 BIO International Convention scheduled for June 8-11 in San Diego to an online platform, in lieu of an in-person event for this year. The decision was based…

BIO Summit Accelerates Collaboration Between Government & Industry Leaders in Fight Against Covid-19

March 25, 2020

The Biotechnology Innovation Organization (BIO) this week hosted a productive virtual summit intended to foster collaboration among key government agencies and biopharmaceutical innovators with one goal: eradicating Covid-19. The two-day virtual…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.